Search

Respimat re-usable wins Pharmapack Eco-Design Award

The Respimat® re-usable inhaler device has won the 2020 Pharmapack Eco-Design Award. An enhanced version of the Respimat® soft mist inhaler, Respimat® re-usable has a lower environmental impact and is easy for patients to use.

Women in STEM 2022

Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM.

Heart murmur in dogs: symptoms and how to treat it

Monitoring your dog’s heart can save its life

Nerandomilast primary endpoint phase-3 FIBRONEER-IPF met

Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study

Vaccine prevent calf diarrhea

Fencovis® is the first vaccine to prevent calf diarrhea caused by E. coli F5 and bovine rotavirus and reduce severity of calf diarrhea caused by bovine coronavirus

Our goal of transforming the treatment of neuroendocrine carcinomas

Our progress in developing a potential DLL3 targeted immunotherapy for neuroendocrine carcinomas (NECs), including small cell lung cancer (SCLC), large cell NEC of the lung (LCNEC-L) and extrapulmonary NEC (epNEC).

Performance Indicators

Performance indicators concerning Environment Health and Safety (EHS) are summarized here.

More Health: For People & Animals

Collaboration with Mary Tyler Moore Vision Initiative

Boehringer Ingelheim joins forces with Mary Tyler Moore Vision Initiative to combat vision loss from diabetes

empa-reg-outcome-recurrent-events

EMPA-REG OUTCOME® analysis: Empagliflozin reduced risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and CV disease

Life forward - Boehringer Ingelheim company brand

Life forward - Boehringer Ingelheim unveils its evolved company brand

In-Reach Africa initiatives successfully completed

We are proud to report the successful completion of Kuza Afya and Tiba Yako, two of our In-Reach Africa initiatives.

Bridging the gap in Generalized Pustular Psoriasis (GPP)

Emmanuelle Clerisme-Beaty, former Head of Clinical Development and Medical Affairs, Dermatology, discusses published insights from GPP patients.

Data Science

Revolutionizing research and development with data driven insights

Corporate Profile

Looking behind the scenes of Afrika Kommt!

Looking behind the scenes of Afrika Kommt! with Sabine and Eunice. I in D&I audio interview with reflections on a program designed to build bridges.

It is about saving lives Alexis Jaliquias feline blood bank

Veterinarian Alexis Jaliquias founded one of the first blood banks for cats in South America

Thinking differently could eradicate some areas of retinal disease

Retinal disease could be eradicated by thinking differently. Degenerative eye conditions can be cured with a patient-first approach, says Dr Victor Chong.

Flood-disaster-in-Germany-donation-from-Boehringer-Ingelheim

Boehringer Ingelheim increases donation for emergency flood relief to EUR 1 million

Closing healthcare gaps with continued vaccination campaigns

How we continue combating rabies through collaborative efforts and the use of drone delivery in rural Kenya.

Breakthrough Designation granted in US and China

SPEVIGO® granted Breakthrough Therapy Designation in the U.S. for the prevention of generalized pustular psoriasis flares

equine asthma

Fighting Equine Asthma is a crucial step to improving the well-being of many horses worldwide. The right treatment can make a world of difference.

How mobile medical clinics tackle health equity Down Under

We support Heart of Australia to improve health in rural communities

Launch of first veterinary vaccines produced in China

Swine vaccine Ingelvac PRRS MLV, produced by Boheringer Ingelheim veterinary vaccine manufacturing plant in Taizhou is now officially supplied to the China market.

Boehringer Ingelheim Academy

Find out more about our networking and educational initiative

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers